Citation Impact
Citing Papers
Antiseptics and Disinfectants: Activity, Action, and Resistance
1999 Standout
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
The Clinical Spectrum of Aspergillosis—Part 1: Epidemiology, Pathogenicity, Infection in Animals and Immunology of Aspergillus
1980
The Clinical Spectrum of Aspergillosis–Part 2: Classification and Description of Saprophytic, Allergic, and Invasive Variants of Human Disease
1980
Cystic fibrosis pulmonary guidelines: airway clearance therapies.
2009
The Pseudomonas aeruginosa accessory genome elements influence virulence towards Caenorhabditis elegans
2019 StandoutNobel
Stroke rehabilitation
2011 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus
2000
Guide to Bone Health and Disease in Cystic Fibrosis
2005
Use of ciprofloxacin in cystic fibrosis patients
1989
Cystic Fibrosis Pulmonary Guidelines
2009
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
2015 Standout
Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity.
1997 Standout
Exposure to an Aeroallergen as a Possible Precipitating Factor in Respiratory Arrest in Young Patients with Asthma
1991 Standout
Lack of Unique Ciprofloxacin Pharmacokinetic Characteristics in Patients with Cystic Fibrosis
1988
Physicochemical and Physiological Mechanisms for the Effects of Food on Drug Absorption: The Role of Lipids and pH
1997
Self-administered chest physiotherapy in cystic fibrosis: A comparative study of high-pressure pep and autogenic drainage
1992
Cystic fibrosis
2016 Standout
Benefits and risks of menopausal estrogen and/or progestin hormone use
1988
The diagnosis of cystic fibrosis: A consensus statement
1998
Pancreatic enzyme replacement therapy for people with cystic fibrosis
2014
Lung Transplantation Outcome in Cystic Fibrosis Patients With Previous Pneumothorax
2005
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
The genome sequence of Rickettsia prowazekii and the origin of mitochondria
1998 StandoutNature
The pathology of fungal infection and colonization in patients with cystic fibrosis
1989
Cystic Fibrosis Pulmonary Guidelines
2007
Tumor necrosis factor α stimulates leukotriene production in vivo
1988 StandoutNobel
Chronic obstructive pulmonary disease
1988
Defining an exacerbation of pulmonary disease in cystic fibrosis*
2001
Blinding in Randomized Clinical Trials: Imposed Impartiality
2011
Lung disease in cystic fibrosis—an updated concept
1990
Vitamin D Deficiency
2007 Standout
Pneumothorax in Cystic Fibrosis
2005
Standardisation of spirometry
2005 Standout
The adolescent brain and age-related behavioral manifestations
2000 Standout
Neural-Tube Defects
1999 Standout
Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis—State of the Art: Cystic Fibrosis Foundation Consensus Conference
2003
Respiratory Arrest in near-Fatal Asthma
1991 Standout
The Effects of Postural Drainage and Positive Expiratory Pressure Physiotherapy on Tracheobronchial Clearance in Cystic Fibrosis
1991
Drug administration by jet nebulization
1998
The Science of Antibiotic Discovery
2020 Standout
Management of spontaneous pneumothorax: British Thoracic Society pleural disease guideline 2010
2010 Standout
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 Standout
Health inequalities in the early years: Is there equalisation in youth?
1997
Management of Pulmonary Disease in Patients with Cystic Fibrosis
1996
Bacterial biofilms: from the Natural environment to infectious diseases
2004 Standout
Long‐term tobramycin aerosol therapy in cystic fibrosis
1989
Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations
1997
Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis
2002
Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis
1999
Salmonella typhi uses CFTR to enter intestinal epithelial cells
1998 StandoutNatureNobel
Pancreatic enzyme replacement therapy for people with cystic fibrosis (Review)
2014
Interpretative strategies for lung function tests
2005 Standout
Pneumothorax in cystic fibrosis: A 26-year experience
1989
Anti-inflammatory effects of montelukast in mild cystic fibrosis
2002
Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis
1994 Standout
Cystic fibrosis: A review of pulmonary infections and interventions
1987
Cystic Fibrosis Pulmonary Guidelines
2013
Airway Mucus Function and Dysfunction
2010 Standout
Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis
1993
Variability of pulmonary function tests in cystic fibrosis
1990
Efficacy of oral fluoroquinolones versus conventional intravenous antipseudomonal chemotherapy in treatment of cystic fibrosis
1987
Cystic Fibrosis Transmembrane Conductance Regulator Mediates the Cyclic Adenosine Monophosphate–Induced Fluid Secretion But Not the Inhibition of Resorption in Mouse Gallbladder Epithelium
1997 StandoutNobel
Immunologic Aspects of Cystic Fibrosis
1988
Umbilical Arterial S-nitrosothiols in Stressed Newborns: Role in Perinatal Circulatory Transition
1998 StandoutNobel
Cystic fibrosis-related bone disease
2013
Cystic fibrosis foundation consensus conference report on pulmonary complications of cystic fibrosis
1993
The Role of Inflammation in the Pathophysiology of CF Lung Disease
2002
Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis
2003
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Technical Report: Precautions Regarding the Use of Aerosolized Antibiotics
2000
Bone density in children and adolescents with cystic fibrosis
1996
BTS guidelines for the management of spontaneous pneumothorax
2003
Pseudomonas aeruginosa Population Structure Revisited
2009
Allergic Bronchopulmonary Aspergillosis in Patients With Cystic Fibrosis
1994
Antimicrobial Therapy Against Staphylococcus aureus, Pseudomonas aeruginosa, and Pseudomonas cepacia
1988
5′‐Adenosinephosphosulphate reductase (CysH) protects Mycobacterium tuberculosis against free radicals during chronic infection phase in mice
2006 StandoutNobel
BTS guidelines for the management of spontaneous pneumothorax
2003
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Cystic Fibrosis Since 1938
2005
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Head and neck aspergillosis in patients undergoing bone marrow transplantation. Report of four cases and review of the literature
1986 StandoutNobel
Electromechanical-assisted training for walking after stroke
2017
Inhaled antibiotics in cystic fibrosis: Is there a therapeutic effect?
1986
Diagnosis and Treatment of Cystic Fibrosis
1984
Immunology of Tuberculosis
2001 Standout
Activation of A3 adenosine receptors on human eosinophils elevates intracellular calcium
1996 StandoutNobel
Identification of nitric oxide synthase as a protective locus against tuberculosis
1997
Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms
2000 StandoutNature
Comparison of Five In Vitro Digestion Models To Study the Bioaccessibility of Soil Contaminants
2002 Standout
Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis
2015
Role of Mutant CFTR in Hypersusceptibility of Cystic Fibrosis Patients to Lung Infections
1996 Science
A rational approach to the nutritional care of patients with cystic fibrosis.
1989
Antibiotic Therapy for Chronic Infection of Pseudomonas in the Lung
1993
Genetics of O-Antigen Biosynthesis inPseudomonas aeruginosa
1999
Effects of Viral Lower Respiratory Tract Infection on Lung Function in Infants With Cystic Fibrosis
1999
Implications of Rewiring Bacterial Quorum Sensing
2007 StandoutNobel
Prevalence of liver disease in cystic fibrosis.
1991
Nitric oxide and the immune response
2001 Standout
Autogenic drainage: a modern approach to physiotherapy in cystic fibrosis.
1989
Activity of biocides against mycobacteria
1996
The ductular cell in pancreatic cystic fibrosis
1965
Bacterial Biofilms: A Common Cause of Persistent Infections
1999 StandoutScience
Biological Properties of the Encapsulated Staphylococcus aureus M
1974
Antiviral Actions of Interferons
2001 Standout
Frequency Of Aspergillus Fumigatus Isolates and Antibodies to Aspergillus Antigens In Cystic Fibrosis
1985
Effect of Dietary Enrichment with Eicosapentaenoic and Docosahexaenoic Acids on in Vitro Neutrophil and Monocyte Leukotriene Generation and Neutrophil Function
1985 StandoutNobel
The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology.
1984
Activity of biocides against mycobacteria
1996
Managing Cough as a Defense Mechanism and as a Symptom
1998
History of asthma deaths from antiquity
1987
FREQUENT ANTIBIOTIC THERAPY IMPROVES SURVIVAL OF CYSTIC FIBROSIS PATIENTS WITH CHRONIC PSEUDOMONAS AERUGINOSA INFECTION
1983
Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection
1987
Efficacy of Aerosolized Tobramycin in Patients with Cystic Fibrosis
1993
Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis
1987
THE EFFECT OF LEUKOTRIENE C4 ON MUCIN RELEASE INTO THE CAT TRACHEA in vivo AND in vitro
1982
Chemistry, physiology, and therapeutic applications of calcitonin
1980
Aspergillus Antibody in Patients With Cystic Fibrosis
1975
Potential of preventing Pseudomonas aeruginosa lung infections in cystic fibrosis patients: Experimental studies in animals
1996
Estrogen and Coronary Heart Disease in Women
1991 Standout
Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment ofPseudomonas aeruginosa colonization in cystic fibrosis
1998
The Mechanism of Isoniazid Killing: Clarity Through the Scope of Genetics
2007
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
ALTERNATE-DAY PREDNISONE REDUCES MORBIDITY AND IMPROVES PULMONARY FUNCTION IN CYSTIC FIBROSIS
1985
Antibacterial Therapy in Cystic Fibrosis
1988
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
1987 StandoutScienceNobel
Pulmonary Disease Associated with Pseudomonas aeruginosa in Cystic Fibrosis: Current Status of the Host-Bacterium Interaction
1985
Lipopolysaccharide Endotoxins
2002 Standout
Microbial Growth in Lipid Emulsions Used in Parenteral Nutrition
1975
Mediation of the Killing of Rough, Mucoid Isolates of Pseudomonas aeruginosa from Patients with Cystic Fibrosis by the Alternative Pathway of Complement
1984
Secretory products of macrophages.
1987 Standout
Effect of tonicity of nebulised colistin on chest tightness and pulmonary function in adults with cystic fibrosis
1997
Functions of Cell Surface Heparan Sulfate Proteoglycans
1999 Standout
The construction and partial characterization of plasmids containing complementary DNA sequences to human calcitonin precursor polyprotein
1981 StandoutNobel
Avirulence and altered physiological properties of cystic fibrosis strains of Pseudomonas aeruginosa
1985
Lung Infections Associated with Cystic Fibrosis
2002 Standout
Talc Poudrage in the Treatment of Spontaneous Pneumothoraces in Patients with Cystic Fibrosis
1986
Within-subject variability and per cent change for significance of spirometry in normal subjects and in patients with cystic fibrosis.
1980 Standout
Effect of Size and Disease on Estimated Deposition of Drugs Administered Using Jet Nebulization in Children With Cystic Fibrosis
2001
Role of Alginate O Acetylation in Resistance of MucoidPseudomonas aeruginosato Opsonic Phagocytosis
2001
Works of John Batten being referenced
Evaluation of the forced expiration technique as an adjunct to postural drainage in treatment of cystic fibrosis.
1979
Infection control revisited: dilemma facing today's bronchoscopists.
1988
Sweat tests to diagnose cystic fibrosis in adults.
1983
Experimental chemotherapy of tuberculosis.
1968
The influence of corticotrophin and certain corticosteroids on populations of Mycobacterium tuberculosis in tissues of mice.
1957
Effect of cimetidine on enzyme inactivation, bile acid precipitation, and lipid solubilisation in pancreatic steatorrhoea due to cystic fibrosis.
1985
Meconium ileus equivalent in adults with cystic fibrosis of pancreas: a report of six cases.
1976
Comparison of the Effect of Alprenolol and Propranolol on Specific Airway Conductance in Asthmatic Subjects
1970
Sudden Death in a Young Asthmatic
1969
AMENORRHOEA IN CYSTIC FIBROSIS
1987
Inhaled ceftazidime compared with gentamicin and carbenicillin in older patients with cystic fibrosis infected with Pseudomonas aeruginosa
1987
A Community-Based, Bionic Leg Rehabilitation Program for Patients with Chronic Stroke: Clinical Trial Protocol
2017
The Relationship of Phenotype Changes in Pseudomonas aeruginosa to the Clinical Condition of Patients with Cystic Fibrosis 1, 2
1983
The arthropathy of cystic fibrosis.
1988
Cystic fibrosis—immunological reactions to A. Fumigatus and common allergens
1975
PRECIPITATING ANTIBODIES TO ASPERGILLUS FUMIGATUS IN CYSTIC FIBROSIS
1967
Effect of intrajejunal acidity on aqueous phase bile acid and lipid concentrations in pancreatic steatorrhoea due to cystic fibrosis.
1984
Importance of viruses and Legionella pneumophila in respiratory exacerbations of young adults with cystic fibrosis.
1984
THE PREVALENCE OF RESPIRATORY DISEASE IN HETEROZYGOTES FOR THE GENE FOR FIBROCYSTIC DISEASE OF THE PANCREAS
1963
ORAL CIPROFLOXACIN COMPARED WITH CONVENTIONAL INTRAVENOUS TREATMENT FOR PSEUDOMONAS AERUGINOSA INFECTION IN ADULTS WITH CYSTIC FIBROSIS
1987
Enteric coated microspheres of pancreatin in the treatment of cystic fibrosis: comparison with a standard enteric coated preparation.
1987
Adverse reactions to piperacillin in adults with cystic fibrosis.
1985
A pathological study following bronchial artery embolization for haemoptysis in cystic fibrosis
1980
Ticarcillin compared with carbenicillin in the treatment of exacerbations of bronchopulmonary infection in cystic fibrosis
1983
AEROSOL CARBENICILLIN AND GENTAMICIN TREATMENT OF PSEUDOMONAS AERUGINOSA INFECTION IN PATIENTS WITH CYSTIC FIBROSIS
1981
Cystic fibrosis: Ultrasonographic findings in the pancreas and hepatobiliary system correlated with clinical data and pathology
1985
Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis.
1984
THE EFFECT OF ANTIMICROBIAL DRUGS ON AN EXPERIMENTAL STAPHYLOCOCCAL INFECTION IN MICE
1956
Vitamin D and parathyroid hormone and bone mineralisation in adults with cystic fibrosis.
1988
Cystic fibrosis in adolescents and adults.
1987
IDENTIFICATION OF LEUKOTRIENES D AND B IN SPUTUM FROM CYSTIC FIBROSIS PATIENTS
1981
Management of pneumothorax in adults with cystic fibrosis.
1982
Tobramycin and carbenicillin compared with gentamicin and carbenicillin in the treatment of infection with Pseudomonas aeruginosa in adult patients with cystic fibrosis.
1983
Pharmacokinetics and sputum penetration of ciprofloxacin in patients with cystic fibrosis
1986